1 |
Ebrahimi F, Noaparast Z, Abedi SM, Hosseinimehr SJ. Homodimer 99mTc-HYNIC-E(SSSLTVPWY)2 peptide improved HER2-overexpressed tumor targeting and imaging. Med Oncol 2022;39:204. [PMID: 36175805 DOI: 10.1007/s12032-022-01798-6] [Reference Citation Analysis]
|
2 |
Sharma AK, Sharma R, Vats K, Sarma HD, Mukherjee A, Das T, Satpati D. Synthesis and comparative evaluation of 177Lu-labeled PEG and non-PEG variant peptides as HER2-targeting probes. Sci Rep 2022;12:15720. [PMID: 36127494 DOI: 10.1038/s41598-022-19201-9] [Reference Citation Analysis]
|
3 |
Verdoliva V, Digilio G, Miletto I, Saviano M, De Luca S. Fluorescence Studies: A9 Peptide, Functionalized with a Fluorogenic Probe, Interacts with Its Receptor Model HER2-DIVMP. ACS Med Chem Lett 2022;13:807-11. [PMID: 35586438 DOI: 10.1021/acsmedchemlett.2c00026] [Reference Citation Analysis]
|
4 |
Van Holsbeeck K, Martins JC, Ballet S. Downsizing antibodies: Towards complementarity-determining region (CDR)-based peptide mimetics. Bioorg Chem 2021;119:105563. [PMID: 34942468 DOI: 10.1016/j.bioorg.2021.105563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
5 |
Ge S, Li J, Yu Y, Chen Z, Yang Y, Zhu L, Sang S, Deng S. Review: Radionuclide Molecular Imaging Targeting HER2 in Breast Cancer with a Focus on Molecular Probes into Clinical Trials and Small Peptides. Molecules 2021;26:6482. [PMID: 34770887 DOI: 10.3390/molecules26216482] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|